Skip to content

A multicenter randomized controlled study for the effect of ERAS pathway management and traditional management on clinical outcomes in laparoscopic-assisted radical gastrectomy for distal gastric cancer

A multicenter randomized controlled study for the effect of ERAS pathway management and traditional management on clinical outcomes in laparoscopic-assisted radical gastrectomy for distal gastric cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022438
Enrollment
Unknown
Registered
2019-04-11
Start date
2019-04-15
Completion date
Unknown
Last updated
2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Sponsors

Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Laparoscopic-assisted radical gastrectomy for distal gastric cancer in 18-75 years old without preoperative neoadjuvant therapy

Exclusion criteria

Exclusion criteria: 1. Patients with stage T4b, M1 and large unresectable tumors; those with malignant tumors in other parts; 2. Previous patients with other malignant tumors and low-grade malignant potential tumors (giant cell tumors of bone, pseudomyxoma of appendix, invasive fibroma); 3. Patients who used opioid analgesics or hormones within 7 days before operation; 4. The patient has suffered from myocardial infarction, heart failure, COPD, severe asthma, chronic renal failure and cirrhosis. 5. Patients with mental disorders such as depression and mania; 6. Pregnant patients.

Design outcomes

Primary

MeasureTime frame
3-year overall survival rate;Progressive-free survival rate;

Secondary

MeasureTime frame
Incidence of total postoperative complications;Incidence of major complications;30-day readmission rate;30-day mortality rate;Hospitalization days and hospitalization expenses;Quality of life of patients;

Countries

China

Contacts

Public ContactYanbing Zhou

Affiliated Hospital of Qingdao University

zhouyanbing999@aliyun.com+86 13708971773

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026